Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 2;14(1):42.
doi: 10.1186/s12348-024-00418-w.

Association between in vitro susceptibility and clinical outcomes in fungal keratitis

Louisa Lu  1 , N Venkatesh Prajna  2 , Prajna Lalitha  2 , Revathi Rajaraman  2 , Muthiah Srinivasan  2 , Benjamin F Arnold  3   4 , Nisha Acharya  3   4   5 , Thomas Lietman  3   4   5 , Jennifer Rose-Nussbaumer  6   7
Affiliations

Association between in vitro susceptibility and clinical outcomes in fungal keratitis

Louisa Lu et al. J Ophthalmic Inflamm Infect. .

Abstract

Purpose: The purpose of this study was to assess the association between antifungal susceptibility as measured by minimum inhibitory concentration (MIC) and clinical outcomes in fungal keratitis.

Methods: This pre-specified secondary analysis of the Mycotic Ulcer Treatment Trial II (MUTT II) involved patients with filamentous fungal keratitis presenting to Aravind Eye Hospitals in South India. Antifungal susceptibility testing for natamycin and voriconazole was performed on all samples with positive fungal culture results according to Clinical and Laboratory Standards Institute Guidelines. The relationship between MIC and clinical outcomes of best-corrected visual acuity, infiltrate or scar size, corneal perforation, need for therapeutic penetrating keratoplasty, and time to re-epithelialization were assessed.

Results: We obtained MIC values from 141 patients with fungal keratitis. The most commonly cultured organisms were Aspergillus (46.81%, n = 66) and Fusarium (44.68%, n = 63) species. Overall, there was no association between antifungal MICs and clinical outcomes. Subgroup analysis revealed that among Fusarium-positive cases, higher voriconazole MIC was correlated with worse three-month best-corrected visual acuity (p = 0.03), increased need for therapeutic penetrating keratoplasty (p = 0.04), and time to re-epithelialization (p = 0.03). No significant correlations were found among Aspergillus-positive cases. There were no significant correlations found between natamycin MIC and clinical outcomes among organism subgroups.

Conclusions: Decreased susceptibility to voriconazole was associated with increased odds of requiring a therapeutic penetrating keratoplasty in Fusarium-positive cases. Susceptibility to natamycin was not associated with any of the measured outcomes.

Keywords: Antifungals; Fungal keratitis; Microbial susceptibility; Minimum inhibitory concentration; Therapeutic penetrating keratoplasty.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Sun CQ, Lalitha P, Prajna NV et al (2014) Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis. Ophthalmology 121(8):1495–1500e1. 10.1016/j.ophtha.2014.03.004 10.1016/j.ophtha.2014.03.004 - DOI - PMC - PubMed
    1. Lalitha P, Sun CQ, Prajna NV et al (2014) In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial. Am J Ophthalmol 157(2):318–326. 10.1016/j.ajo.2013.10.004 10.1016/j.ajo.2013.10.004 - DOI - PMC - PubMed
    1. Rodriguez-Tudela JL, Alcazar-Fuoli L, Cuesta I et al (2008) Clinical relevance of resistance to antifungals. Int J Antimicrob Agents 32:S111–S113. 10.1016/S0924-8579(08)70010-4 10.1016/S0924-8579(08)70010-4 - DOI - PubMed
    1. Rex JH, Pfaller MA (2002) Has antifungal susceptibility testing come of age? Clin Infect Dis 35(8):982–989. 10.1086/342384 10.1086/342384 - DOI - PubMed
    1. Shapiro BL, Lalitha P, Loh AR et al (2010) Susceptibility testing and clinical outcome in fungal keratitis. Br J Ophthalmol 94(3):384–385. 10.1136/bjo.2009.158675 10.1136/bjo.2009.158675 - DOI - PubMed